Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Страна 1 од 521 резултати
Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
The purpose of this article is to examine the effects of lutein supplementation on visual acuity, central visual-field area, and subjective visual disturbances in retinitis pigmentosa (RP) and related retinal degenerations, in an international study population recruited via an Internet
Lycopene but not lutein nor zeaxanthin decreases in serum and lipoproteins in age-related macular degeneration patients.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
Epidemiological studies have established that a low serum concentration of carotenoids was associated with risk of Age-Related Macular Degeneration (ARMD). The aim of this study was to determine carotenoid levels in serum and in different lipoprotein fractions in patients diagnosed for
Lutein and zeaxanthin for macular degeneration.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
The effects of increasing lutein and zeaxanthin dosages in people with age-related macular degeneration (AMD) are discussed.
CONCLUSIONS
AMD is a disorder of the macula, the area associated with the sharpest visual acuity. AMD is classified as dry (nonneovascular) or wet (neovascular) and
[Lutein and antioxidants in the prevention of age-related macular degeneration].
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Demographic developments in Europe and North America are causing an increase of age-related diseases. Age-related macular degeneration (AMD) is one of the leading causes of severe central visual acuity loss in elderly people and seems to be an economic problem, too. There is evidence that oxidative
Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
To determine macular pigment (MP) optical density (OD) in patients with ABCA4-associated retinal degenerations (ABCA4-RD) and the response of MP and vision to supplementation with lutein.
METHODS
Patients with Stargardt disease or cone-rod dystrophy and known or suspected disease-causing
Role of lutein supplementation in the management of age-related macular degeneration: meta-analysis of randomized controlled trials.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
The conduct of this meta-analysis aimed at examining the individual role of lutein as a dietary supplement in improving conditions of age-related macular degeneration (AMD) from the data generated from randomized controlled trials (RCTs).
METHODS
The literature search was made in multiple
Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
To estimate the effect of dietary intake of lutein and zeaxanthin (L/Z) and fats on the progression of age-related macular degeneration (AMD).
METHODS
Two hundred and fifty-four subjects identified with early age-related macular degeneration (AMD) were re-examined to determine 7-year AMD
Efficacy of Ethanol Extract of Fructus lycii and Its Constituents Lutein/Zeaxanthin in Protecting Retinal Pigment Epithelium Cells against Oxidative Stress: In Vivo and In Vitro Models of Age-Related Macular Degeneration.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Age-related macular degeneration (AMD) is a major cause of blindness worldwide. Oxidative stress plays a large role in the pathogenesis of AMD. The present study was to evaluate the effects of Fructus lycii ethanol extract on AMD in mice and to investigate whether combination of lutein and
Effects of Lutein Supplementation in Japanese Patients with Unilateral Age-Related Macular Degeneration: The Sakai Lutein Study.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
This prospective randomized double-masked study investigated the effects of 20 mg lutein supplementation with two different capsules (beeswax or glycerol fatty acid esters) for 6 months on the fellow eyes of 39 Japanese patients with unilateral age-related macular degeneration, and assessed the
Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
To examine the effects of lutein and zeaxanthin supplementation on retinal function using multifocal electroretinograms (mfERG) in patients with early age-related macular degeneration (AMD).
METHODS
Randomized, double-masked, placebo-controlled trial.
METHODS
One hundred eight subjects
Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND
The association between lutein/zeaxanthin intake and age-related macular degeneration (AMD) risk may differ by smoking status, vitamin C and E intakes, and body fatness.
OBJECTIVE
The objective was to evaluate the association between lutein/zeaxanthin intake and AMD risk by smoking
Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
To determine whether supplementation with lutein and zeaxanthin improves macular pigment and visual function in patients with early age-related macular degeneration (AMD).
METHODS
Randomized, double-masked, placebo-controlled trial.
METHODS
Participants with probable AMD who were 50 to 79
Lutein and Factor D: two intriguing players in the field of age-related macular degeneration.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Age-related macular degeneration (AMD) is a progressive eye disease that impairs central vision among elderly populations in Western, industrialized countries. In this review we will focus on the role of factor D (FD) and lutein in AMD. FD is a rate-limiting enzyme of the alternative complement
Lutein and zeaxanthin intakes and risk of age-related macular degeneration and cataracts: an evaluation using the Food and Drug Administration's evidence-based review system for health claims.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The labeling of health claims that meet the significant scientific agreement standard and of qualified health claims on conventional foods and dietary supplements requires premarket approval by the Food and Drug Administration (FDA). The FDA conducts an evidence-based review to ascertain whether
[Prevention and treatment of age-related macular degeneration by extract of Fructus lycii and its constituents lutein/zeaxanthin: an in vive and in vitro experimental research].
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE
To investigate the in vivo inhibition of extract of Fructus lycii (FL) on the expressions of cathepsin B (Cat B) and cystatin C (Cys C) in high-fat diet and hydroquinone (HQ) induced model mice with age-related macular degeneration (AMD), and to explore the in vitro effects of lutein and
Најкомплетнија база лековитог биља подржана науком
- Ради на 55 језика
- Биљни лекови потпомогнути науком
- Препознавање биљака по слици
- Интерактивна ГПС мапа - означите биље на локацији (ускоро)
- Читајте научне публикације повезане са вашом претрагом
- Претражите лековито биље по њиховим ефектима
- Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима
Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима
